Tender Details

Country: USA
Summary: Nci Clinical And Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
UST Ref No: 109656397
Deadline: 01 Jul 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: USD 200000
Notice Type: Tender
Document Ref. No.: PAR-25-139
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Through This Notice Of Funding Opportunity (Nofo), The National Cancer Institute (Nci) Intends To Supports The Development Of New Exploratory Research In Cancer Diagnosis, Treatment, Imaging, Symptom/Toxicity, And Prevention Clinical Trials; Correlative Studies Associated With Clinical Trials; Novel Cancer Therapeutic, Symptom/Toxicity, And Preventive Agent Development, Radiotherapy Development Activities, And Mechanism-Driven Combinations; And Innovative Preclinical Studies--Including The Use Of New Clinically-Relevant Models And Imaging Technologies--Which Could Lead To First-In-Human Clinical Trials. The R21 Mechanism Is Intended To Encourage Exploratory And Developmental Research Projects By Providing Support For The Early And Conceptual Stages Of These Projects. These Studies May Involve Considerable Risk But May Lead To A Breakthrough In A Particular Area, Or To The Development Of Novel Techniques, Agents, Methodologies, Models, Or Applications That Could Have A Major Impact On A Field Of Cancer Research (Pre-Clinical Or Clinical).
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Nci Clinical And Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Nci Clinical And Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 109656397 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-01.

The estimated tender value is USD 200000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.